Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$1.8 - $4.28 $35,514 - $84,444
-19,730 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$3.16 - $5.15 $62,346 - $101,609
19,730 New
19,730 $82,000
Q3 2019

Nov 14, 2019

SELL
$1.2 - $6.66 $20,049 - $111,275
-16,708 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$5.35 - $7.11 $89,387 - $118,793
16,708 New
16,708 $105,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $313M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.